Detalles de la búsqueda
1.
Multisegmented esophageal fully covered self-expandable metal stent for palliation of malignant dysphagia: a prospective, multicenter feasibility and safety study.
Gastrointest Endosc
; 99(6): 1027-1031.e6, 2024 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38316224
2.
A Prediction Model for Successful Increase of Adalimumab Dose Intervals in Patients with Crohn's Disease: Secondary Analysis of the Pragmatic Open-Label Randomised Controlled Non-inferiority LADI Trial.
Dig Dis Sci
; 69(6): 2165-2174, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38594435
3.
Feasibility of Reduced Clinical Monitoring in Patients with Inflammatory Bowel Disease Treated with Thiopurine Therapy.
Dig Dis Sci
; 68(7): 2936-2945, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37131100
4.
Long-Term Clinical Outcomes After Switching from Remicade® to Biosimilar CT-P13 in Inflammatory Bowel Disease.
Dig Dis Sci
; 62(11): 3117-3122, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28667429
5.
Identification of Patients With Variants in TPMT and Dose Reduction Reduces Hematologic Events During Thiopurine Treatment of Inflammatory Bowel Disease.
Gastroenterology
; 149(4): 907-17.e7, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26072396
6.
Recognition of Coxiella burnetii by toll-like receptors and nucleotide-binding oligomerization domain-like receptors.
J Infect Dis
; 211(6): 978-87, 2015 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25246533
7.
Prior colorectal neoplasia is associated with increased risk of ileoanal pouch neoplasia in patients with inflammatory bowel disease.
Gastroenterology
; 146(1): 119-28.e1, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24076060
8.
Allopurinol and 5-aminosalicylic acid influence thiopurine-induced hepatotoxicity in vitro.
Cell Biol Toxicol
; 31(3): 161-71, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25916701
9.
Intrauterine exposure and pharmacology of conventional thiopurine therapy in pregnant patients with inflammatory bowel disease.
Gut
; 63(3): 451-7, 2014 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-23424097
10.
Healthcare costs of inflammatory bowel disease have shifted from hospitalisation and surgery towards anti-TNFα therapy: results from the COIN study.
Gut
; 63(1): 72-9, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23135759
11.
Recognition of Streptococcus pneumoniae and muramyl dipeptide by NOD2 results in potent induction of MMP-9, which can be controlled by lipopolysaccharide stimulation.
Infect Immun
; 82(12): 4952-8, 2014 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-25183734
12.
GST Theta null genotype is associated with an increased risk for ulcerative colitis: a case-control study and meta-analysis of GST Mu and GST Theta polymorphisms in inflammatory bowel disease.
J Hum Genet
; 59(10): 575-80, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25186055
13.
Myosin IXb variants and their pivotal role in maintaining the intestinal barrier: a study in Crohn's disease.
Scand J Gastroenterol
; 49(10): 1191-200, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25098938
14.
Respiratory syncytial virus infection augments NOD2 signaling in an IFN-ß-dependent manner in human primary cells.
Eur J Immunol
; 42(10): 2727-35, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22730064
15.
Increased versus conventional adalimumab dose interval for patients with Crohn's disease in stable remission (LADI): a pragmatic, open-label, non-inferiority, randomised controlled trial.
Lancet Gastroenterol Hepatol
; 8(4): 343-355, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36736339
16.
Cost-Effectiveness Analysis of Increased Adalimumab Dose Intervals in Crohn's Disease Patients in Stable Remission: The Randomized Controlled LADI Trial.
J Crohns Colitis
; 17(11): 1771-1780, 2023 Nov 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37310877
17.
Analysis of SNPs with an effect on gene expression identifies UBE2L3 and BCL3 as potential new risk genes for Crohn's disease.
Hum Mol Genet
; 19(17): 3482-8, 2010 Sep 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20601676
18.
Infliximab exerts no direct hepatotoxic effect on HepG2 cells in vitro.
Dig Dis Sci
; 57(6): 1604-8, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-22535279
19.
Crohn's disease-associated ATG16L1 polymorphism modulates pro-inflammatory cytokine responses selectively upon activation of NOD2.
Gut
; 60(9): 1229-35, 2011 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21406388
20.
Appropriate infliximab infusion dosage and monitoring: results of a panel meeting of rheumatologists, dermatologists and gastroenterologists.
Br J Clin Pharmacol
; 71(1): 7-19, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21143496